Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $1.714B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 8,142,100 | $464M | 27.1% | $10.52 | +424.7% | CLASS A ORD | 61559X104 |
| BBIO | BRIDGEBIO PHARMA INC | 4,662,530 | $123M | 7.2% | $17.77 | +59.7% | COM | 10806X102 |
| — | AMBRX BIOPHARMA INC | 9,923,689 | $114M | 6.7% | $12.20 | — | SPONSORED ADS | 02290A102 |
| ACLX | ARCELLX INC | 2,150,000 | $77.14M | 4.5% | $21.44 | +60.8% | COMMON STOCK | 03940C100 |
| APLS | APELLIS PHARMACEUTICALS INC | 2,000,000 | $76.08M | 4.4% | $42.18 | +4.2% | COM | 03753U106 |
| — | CYMABAY THERAPEUTICS INC | 3,850,000 | $57.4M | 3.3% | $10.27 | — | COM | 23257D103 |
| OLMA | OLEMA PHARMACEUTICALS INC | 4,504,764 | $55.63M | 3.2% | $25.80 | -60.5% | COM | 68062P106 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,056,373 | $53.26M | 3.1% | $35.89 | — | SPONSORED ADS | 86366E106 |
| BMEA | BIOMEA FUSION INC | 3,570,872 | $49.14M | 2.9% | $17.07 | +5.6% | COM | 09077A106 |
| IMVT | IMMUNOVANT INC | 1,225,000 | $47.03M | 2.7% | $20.83 | +8.5% | COM | 45258J102 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,621,422 | $46.58M | 2.7% | $21.36 | -17.2% | COM | 87650L103 |
| CABA | CABALETTA BIO INC | 2,879,424 | $43.82M | 2.6% | $9.97 | +37.0% | COM | 12674W109 |
| PCVX | VAXCYTE INC | 665,000 | $33.9M | 2.0% | $44.03 | +12.1% | COM | 92243G108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,101,904 | $32.77M | 1.9% | $20.61 | 0.0% | COM | 22663K107 |
| IMRX | IMMUNEERING CORP | 4,204,364 | $32.29M | 1.9% | $18.88 | -51.3% | CLASS A COM | 45254E107 |
| PHVS | PHARVARIS N V | 1,361,460 | $28.41M | 1.7% | $21.81 | -15.5% | COM | N69605108 |
| — | RAYZEBIO INC | 1,182,263 | $26.25M | 1.5% | $22.20 | — | COM | 75525N107 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 3,200,000 | $25.57M | 1.5% | $5.93 | +85.0% | COM NEW | 30233G209 |
| — | KARUNA THERAPEUTICS INC | 140,000 | $23.67M | 1.4% | $154.26 | — | COM | 48576A100 |
| — | ALPINE IMMUNE SCIENCES INC | 1,900,000 | $21.75M | 1.3% | $11.45 | — | COM | 02083G100 |
| ERAS | ERASCA INC | 10,813,246 | $21.3M | 1.2% | $20.23 | -87.3% | COM | 29479A108 |
| — | AEROVATE THERAPEUTICS INC | 1,561,696 | $21.19M | 1.2% | $20.58 | — | COM | 008064107 |
| — | MARINUS PHARMACEUTICALS INC | 2,625,000 | $21.13M | 1.2% | $8.05 | — | COM NEW | 56854Q200 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 850,000 | $19.49M | 1.1% | $19.33 | +15.9% | COM | 76243J105 |
| EWTX | EDGEWISE THERAPEUTICS INC | 2,946,887 | $16.89M | 1.0% | $25.59 | -73.4% | COM | 28036F105 |
| ELVN | ENLIVEN THERAPEUTICS INC | 1,216,712 | $16.62M | 1.0% | $20.34 | -17.2% | COM | 29337E102 |
| — | PRAXIS PRECISION MEDICINES I | 9,500,000 | $16.25M | 0.9% | $1.15 | — | COM | 74006W108 |
| IDYA | IDEAYA BIOSCIENCES INC | 600,000 | $16.19M | 0.9% | $16.14 | +57.1% | COM | 45166A102 |
| INSM | INSMED INC | 575,000 | $14.52M | 0.8% | $22.87 | 0.0% | COM PAR $.01 | 457669307 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 700,000 | $14.04M | 0.8% | $23.99 | +5.8% | COM | 98943L107 |
| — | AXONICS INC | 250,000 | $14.03M | 0.8% | $15.11 | — | COM | 05465P101 |
| — | LONGBOARD PHARMACEUTICALS IN | 2,353,141 | $13.08M | 0.8% | $14.61 | — | COM | 54300N103 |
| RNAM | AVIDITY BIOSCIENCES INC | 1,762,115 | $11.24M | 0.7% | $25.05 | -65.6% | COM | 05370A108 |
| IRON | DISC MEDICINE INC | 225,000 | $10.57M | 0.6% | $35.48 | +41.0% | COM | 254604101 |
| COGT | COGENT BIOSCIENCES INC | 1,000,000 | $9.75M | 0.6% | $10.55 | +12.5% | COM | 19240Q201 |
| RCKT | ROCKET PHARMACEUTICALS INC | 450,000 | $9.22M | 0.5% | $16.47 | +10.3% | COM | 77313F106 |
| GHRS | GH RESEARCH PLC | 593,043 | $5.96M | 0.3% | $20.43 | -43.4% | ORDINARY SHARES | G3855L106 |
| — | RAPT THERAPEUTICS INC | 325,000 | $5.402M | 0.3% | $18.35 | — | COM | 75382E109 |
| — | VERVE THERAPEUTICS INC | 350,000 | $4.641M | 0.3% | $49.89 | — | COM | 92539P101 |
| STOK | STOKE THERAPEUTICS INC | 1,087,807 | $4.286M | 0.3% | $26.85 | -75.5% | COM | 86150R107 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 561,600 | $3.634M | 0.2% | $15.97 | — | SPONSORED ADS | 152309100 |
| — | VIGIL NEUROSCIENCE INC | 616,786 | $3.324M | 0.2% | $6.82 | — | COM | 92673K108 |
| ALXO | ALX ONCOLOGY HLDGS INC | 612,079 | $2.938M | 0.2% | $42.62 | -87.3% | COM | 00166B105 |
| BHVN | BIOHAVEN LTD | 81,963 | $2.132M | 0.1% | $14.12 | +47.2% | COM | G1110E107 |
| BCAB | BIOATLA INC | 1,181,115 | $2.008M | 0.1% | $19.72 | -87.1% | COM | 09077B104 |
| NMRA | NEUMORA THERAPEUTICS INC. | 92,293 | $1.302M | 0.1% | $12.87 | 0.0% | COM | 640979100 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 392,167 | $914K | 0.1% | $31.47 | — | SPON ADS | 05280R100 |
| — | HARPOON THERAPEUTICS INC | 54,060 | $218K | 0.0% | $4.03 | — | COM NEW | 41358P205 |
| — | ORCHARD THERAPEUTICS PLC | 25,664 | $198K | 0.0% | $5.38 | — | SPON ADS NEW | 68570P200 |